206 care center directors sign a letter citing clinical consequences if decision moves forward.
Dec. 19, 2022
|
3 min read
Vertex’s copay assistance changes add an undue burden for people living with an already expensive, challenging lifelong disease.
Nov. 23, 2022
|
3 min read
Bill will jump-start rebuilding of the antibiotics pipeline that is vital to stave off a looming pandemic.
Nov. 16, 2022
|
3 min read
Orkambi® is now approved for use in children with cystic fibrosis ages 1-2 years who have two F508del mutations. This is the only modulator available to very young children with these mutations.
Sept. 2, 2022
|
3 min read
The law signals major improvements in health care affordability for people with CF.
Aug. 23, 2022
|
3 min read